Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticleCurrent Practice

Urinary tract infections in pregnancy

Monica Lee, Pina Bozzo, Adrienne Einarson and Gideon Koren
Canadian Family Physician June 2008, 54 (6) 853-854;
Monica Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pina Bozzo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrienne Einarson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gideon Koren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

ABSTRACT

QUESTION My pregnant patients often present with urinary tract infections. Are the medications commonly used for the management of urinary tract infections safe to use during pregnancy?

ANSWER Existing data indicate that exposure to penicillins, cephalosporins, fluoroquinolones, nitrofurantoin, or phenazopyridine during pregnancy is not associated with increased risk of fetal malformations. Trimethoprim-sulfamethoxazole should be avoided, if possible, during the first trimester of pregnancy because of the antifolate effect associated with neural tube defects.

Urinary tract infections (UTIs) are a common complication of pregnancy. Symptomatic UTI occurs in 1% to 2% of pregnancies, while asymptomatic bacteriuria has been reported in 2% to 13% of pregnant women.1 Several anatomical and hormonal changes in pregnant women lead to ureteral dilatation and urinary stasis,2 which contribute to the increased risk of developing UTIs. Untreated UTIs can lead to complications, such as pyelonephritis, low-birth-weight infants, premature delivery, and, occasionally, stillbirth3; therefore, prompt treatment of symptomatic UTIs and asymptomatic bacteriuria is warranted in pregnant women.

Penicillins

Penicillins, such as amoxicillin, are commonly prescribed for the treatment of UTIs. The Collaborative Perinatal Project monitored 3546 mothers who were exposed to penicillin derivatives during their first trimesters, and 7171 mothers who were exposed at any time during their pregnancies. There was no increase noted in the rate of malformations.4 The Michigan Medicaid surveillance study found that among 8538 newborns exposed to amoxicillin during the first trimester, a total of 317 (3.7%) major birth defects were observed, which is within the population risk.5

Cephalosporins

Cephalosporins are alternative antibiotics for treating UTIs. Cephalexin is among the most commonly prescribed oral cephalosporin for this indication.3 In the Michigan Medicaid surveillance study, a total of 176 (4.9%) major birth defects were observed (154 expected) among the 3613 newborns exposed to cephalexin during the first trimester.5 The results of a Hungarian case-control study did not indicate human teratogenic potential for oral cephalexin.6

Fluoroquinolones

Fluoroquinolones are also commonly prescribed for the treatment of UTIs, and include norfloxacin and ciprofloxacin. Concerns regarding the safety of this class of drugs originated from reports of arthropathy in animal studies7; such reports are rare in human cases.8,9 Nevertheless, the safety of these drugs in pregnancy has been explored in a number of studies.10–15 Based on existing data, fluoroquinolone exposure during human gestation is not associated with increased risk of major malformations, adverse effects in the fetal musculoskeletal system, spontaneous abortions, prematurity, intrauterine growth retardation, or postnatal disorders. However, because of the relatively higher cost of these agents and the concern about the emergence of antibiotic-resistant pathogens with frequent use, fluoroquinolones should not routinely be employed as first-line agents in uncomplicated UTIs.

Nitrofurantoin

Numerous studies have demonstrated the safety of nitrofurantoin in pregnancy. Case-control studies and case series involving thousands of women who received nitrofurantoin in pregnancy reported no increase in major malformations among the newborns.5,16,17 In addition, a meta-analysis conducted by Motherisk failed to show teratogenic risk with first-trimester use of nitrofurantoin.18 The drug can theoretically induce hemolytic anemia in the fetus or newborn, particularly in those with glucose-6-phosphate dehydrogenase deficiency; however, cases of this toxicity are rare.19,20

Phenazopyridine

Phenazopyridine is used to relieve UTI symptoms, such as burning, pain, urgency, and frequency, associated with irritation of the lower urinary tract caused by infection. The Collaborative Perinatal Project monitored 219 women with first-trimester exposure and 1109 women with exposure at any time during pregnancy. There was no increase in the rates of major malformations or any other adverse effects.4

Trimethoprim-sulfamethoxazole

Trimethoprim-sulfamethoxazole (TMP-SMX) combination is widely used to treat UTIs. Sulfonamides as a group do not appear to pose a serious teratogenic risk21; however, trimethoprim is a folic acid antagonist and its use during the first trimester has been associated with structural defects, such as neural tube and cardiovascular defects. A detailed review of this drug was published in a previous Motherisk Update.22 Whenever clinically feasible, trimethoprim alone or TMP-SMX combinations should be avoided during the first trimester of pregnancy. Also, sulfamethoxazole can persist in neonatal circulation for several days after delivery if taken near term. There is a theoretical risk of sulfonamides increasing unbound bilirubin owing to competitive protein binding21; however, there have been no reports in the literature of this actually occurring. As other drugs are available and there is potential toxicity to the newborn, TMP-SMX should be avoided after 32 weeks of gestation.22

Conclusion

Urinary tract infections during pregnancy can lead to serious consequences if left untreated. Antibiotics commonly used for this condition have not been found to be associated with an increased risk of birth defects when used during pregnancy. Using products containing trimethoprim is discouraged during the first trimester, and sulfonamides should be avoided in late pregnancy.

Footnotes

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    DwyerPLO’ReillyMRecurrent urinary tract infection in the femaleCurr Opin Obstet Gynecol200214553743
    OpenUrlCrossRefPubMed
  2. ↵
    LeJBriggsGGMcKeownABustilloGUrinary tract infections during pregnancyAnn Pharmacother200438101692701Epub 2004 Aug 31
    OpenUrlCrossRefPubMed
  3. ↵
    ChristensenBWhich antibiotics are appropriate for treating bacteriuria in pregnancy?J Antimicrob Chemother200046Suppl 12934
    OpenUrlAbstract/FREE Full Text
  4. ↵
    HeinonenOPSloneDShapiroSBirth defects and drugs in pregnancyLittleton, MAPublishing Sciences Group1977297313435
  5. ↵
    BriggsGGFreemanRKYaffeSJDrugs in pregnancy and lactation7Philadelphia, PALippincott Williams & Wilkins2005742681153
  6. ↵
    CzeizelAERockenbauerMSørensenHTOlsenJUse of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control studyAm J Obstet Gynecol20011846128996
    OpenUrlCrossRefPubMed
  7. ↵
    InghamBBrentnallDWDaleEAMcFadzeanJAArthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acidsToxicol Lett19771216
    OpenUrlCrossRef
  8. ↵
    ChevaisMPReinertPRondeauMCTobelemRAlbengresERiantPCritical risk/benefit analysis of pefloxacine use in children under 15 years—the problem of arthralgiasInt J Clin Pharmacol Ther Toxicol19872563069
    OpenUrlPubMed
  9. ↵
    ChyskyVKapilaKHullmannRArcieriGSchachtPEchlosRSafety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluationInfection199119428996
    OpenUrlCrossRefPubMed
  10. ↵
    BerkovitchMPastuszakAGazarianMLewisMKorenGSafety of the new quinolones in pregnancyObstet Gynecol19948445358
    OpenUrlPubMed
  11. PastuszakAAndreouRSchickBSageSCookLDonnenfeldANew postmarketing surveillance data supports a lack of association between quinolone use in pregnancy and fetal and neonatal complicationsReprod Toxicol19959584
    OpenUrl
  12. SchaeferCAmoura-ElefantEVialTOrnoyAGarbisHRobertEPregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS)Eur J Obstet Gynecol Reprod Bio1996692839
    OpenUrl
  13. LoebsteinRAddisAHoEAndreouRSageSDonnenfeldAEPregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled studyAntimicrob Agents Chemother199842613369
    OpenUrlAbstract/FREE Full Text
  14. WiltonLVPearceGLMannRDA comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studiesBr J Clin Pharmacol199641427784
    OpenUrlCrossRefPubMed
  15. ↵
    LarsenHNielsenGLSchønheyderHCOlesenCSørensenHTBirth outcome following maternal use of fluoroquinolonesInt J Antimicrob Agents200118325962
    OpenUrlCrossRefPubMed
  16. ↵
    HaileyFJFortHWilliamsJCHammersBFoetal safety of nitrofurantoin macrocrystals therapy during pregnancy: a retrospective analysisJ Int Med Res19831163649
    OpenUrlPubMed
  17. ↵
    CzeizelAERockenbauerMSørensenHTOlsenJNitrofurantoin and congenital abnormalitiesEur J Obstet Gynecol Reprod Biol200195111926
    OpenUrlCrossRefPubMed
  18. ↵
    Ben DavidSEinarsonTBen DavidYNulmanIPastuszakAKorenGThe safety of nitrofurantoin during the first trimester of pregnancy: meta-analysisFundam Clin Pharmacol1995955037
    OpenUrlPubMed
  19. ↵
    GaitJEHemolytic reactions to nitrofurantoin in patients with glucose-6-phasephate dehydrogenase deficiency: theory and practiceDICP1990241212103
    OpenUrlPubMed
  20. ↵
    BruelHGuillemantVSaladin-ThironCChabrolleJPLaharyAPoinsotJ[Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy.]Arch Pediatr2000777457French
    OpenUrlCrossRefPubMed
  21. ↵
    Sulfamethoxazole/trimethoprim [Product Monograph]RepchinskyCCompendium of pharmaceuticals and specialties. The Canadian drug reference for health professionalsOttawa, ONCanadian Pharmacists Association200722548
  22. ↵
    SivojelezovaAEinarsonAShuhaiberSKorenGTrimethoprim-sulfonamide combination therapy in early pregnancyCan Fam Physician20034910856
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Canadian Family Physician: 54 (6)
Canadian Family Physician
Vol. 54, Issue 6
1 Jun 2008
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Urinary tract infections in pregnancy
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Urinary tract infections in pregnancy
Monica Lee, Pina Bozzo, Adrienne Einarson, Gideon Koren
Canadian Family Physician Jun 2008, 54 (6) 853-854;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Urinary tract infections in pregnancy
Monica Lee, Pina Bozzo, Adrienne Einarson, Gideon Koren
Canadian Family Physician Jun 2008, 54 (6) 853-854;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Penicillins
    • Cephalosporins
    • Fluoroquinolones
    • Nitrofurantoin
    • Phenazopyridine
    • Trimethoprim-sulfamethoxazole
    • Conclusion
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Considerations when prescribing trimethoprim-sulfamethoxazole
  • Google Scholar

More in this TOC Section

Current Practice

  • Scurvy
  • Intraprofessional relationships
  • Safety of hair products during pregnancy
Show more Current Practice

Motherisk Update

  • Hepatitis A infection during pregnancy
  • Fluconazole use during breastfeeding
  • Is it safe to breastfeed while taking methylphenidate?
Show more Motherisk Update

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire